AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26011337 — intervention group
Group type: COMPARATOR
Intervention: Postoperative parenteral nutrition (PN)
Number of subjects: 400
Study 23420502 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ergocalciferol
Number of subjects: 20
Study 23420502 — intervention group
Group type: COMPARATOR
Intervention: Control (no ergocalciferol)
Number of subjects: 20
Study 21289227 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels measured in quartiles and clinical cut points (<50, 50-<75, ≥ 75 nmol/L)
Number of subjects: 5140
Study 21289227 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D levels as a continuous variable
Number of subjects: 5140
Study 21289227 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation by strata of BMI, race/ethnicity, or randomization status in the Calcium Vitamin D trial
Number of subjects: 5140
Study 19472447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10-mg ODT
Number of subjects: 207
Study 19472447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 19472447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan + education
Number of subjects: 207
Study 19472447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan + no education
Number of subjects: 207
Study 17904942 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional detailed self-monitoring method
Number of subjects: 42
Study 17904942 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated self-monitoring method
Number of subjects: 42
Study 17904942 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring diaries completed
Number of subjects: 42
Study 15180119 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral tangential focusing with ultrasound-guided ESWT
Number of subjects: 41
Study 15180119 — intervention group
Group type: COMPARATOR
Intervention: Back tangential focusing with ultrasound-guided ESWT
Number of subjects: 41
Study 11679918 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus toxoids-acellular pertussis (DTaP) combined with PRP-tetanus conjugate (PRP-T) vaccine
Number of subjects: 0
Study 9575391 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy adults
Number of subjects: 0
Study 9575391 — intervention group
Group type: COMPARATOR
Intervention: Individuals with chronic illnesses (multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus)
Number of subjects: 0
Study 9575391 — intervention group
Group type: COMPARATOR
Intervention: Healthy elderly individuals
Number of subjects: 0
Study 7841965 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment alone
Number of subjects: 309
Study 7841965 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drug and surgical treatment (endometrial resection or hysterectomy)
Number of subjects: 309
Study 3347762 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent instruction
Number of subjects: 61
Study 3347762 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent instruction
Number of subjects: 61
Study 30251598 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg single oral dose
Number of subjects: 32
Study 27440518 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg edoxaban
Number of subjects: 8292
Study 27440518 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg edoxaban
Number of subjects: 8292
Study 27440518 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 8292
Study 25427999 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training group (TG; n=16)
Number of subjects: 26
Study 25427999 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; n=10)
Number of subjects: 26
Study 23448939 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytonutrient supplement (blended fruit and vegetable juice powder concentrate)
Number of subjects: 684
Study 23448939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 684
Study 23448939 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytonutrient supplement
Number of subjects: 684
Study 20873911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) group (n = 42)
Number of subjects: 116
Study 20873911 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group (n = 74)
Number of subjects: 116
Study 18487886 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 0
Study 16759511 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic group (PG) receiving curosurf immediately after admission
Number of subjects: 100
Study 14551843 — intervention group
Group type: EXPERIMENTAL
Intervention: Patella resurfacing during total knee arthroplasty
Number of subjects: 50
Study 14551843 — intervention group
Group type: COMPARATOR
Intervention: No patella resurfacing during total knee arthroplasty
Number of subjects: 50
Study 11641316 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 1292
Study 11641316 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 1292
Study 11641316 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 1292
Study 11641316 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 1292
Study 11641316 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 1292
Study 11641316 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 1292
Study 11641316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1292
Study 9410284 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasp maneuver for inspiratory muscle strength measurement in ILD patients with normal static compliance (group A)
Number of subjects: 18
Study 9410284 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasp maneuver for inspiratory muscle strength measurement in ILD patients with decreased static compliance (group B)
Number of subjects: 18
Study 1314192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg
Number of subjects: 19
Study 1314192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 3971673 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-free mass estimation using body weight and skinfold thickness
Number of subjects: 104
Study 3971673 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body potassium and nitrogen measurements
Number of subjects: 104
Study 3971673 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor analysis of fat-free tissue measures
Number of subjects: 104
Study 29891397 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal irrigation (NaCl .9%) followed by forced nasal inspiration
Number of subjects: 44
Study 29891397 — intervention group
Group type: COMPARATOR
Intervention: Normal activities (Control Group)
Number of subjects: 44
Study 28763413 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor-sparing block (0.5% ropivacaine, 2.5 μg/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac)
Number of subjects: 82
Study 28763413 — intervention group
Group type: COMPARATOR
Intervention: Periarticular infiltration (0.3% ropivacaine, 2.5 μg/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac)
Number of subjects: 82
Study 28763413 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor-sparing block
Number of subjects: 82
Study 28763413 — intervention group
Group type: COMPARATOR
Intervention: Periarticular infiltration
Number of subjects: 82
Study 28763413 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor-sparing block and periarticular infiltration
Number of subjects: 82
Study 25777669 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (serum PSA reading)
Number of subjects: 4276
Study 25777669 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no diagnostic tests)
Number of subjects: 4276
Study 25777669 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 4276
Study 25777669 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 4276
Study 25777669 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 4276
Study 23347176 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg every other day plus folic acid 5 mg daily
Number of subjects: 83
Study 23347176 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil 10 mg every other day plus placebo daily
Number of subjects: 83
Study 21181186 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID group (n = 6)
Number of subjects: 20
Study 21181186 — intervention group
Group type: COMPARATOR
Intervention: No-NSAID group (n = 14)
Number of subjects: 20
Study 21181186 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID group
Number of subjects: 20
Study 21181186 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 19927474 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients rated themselves as having good adherence
Number of subjects: 238
Study 19927474 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians rated patients as having good adherence
Number of subjects: 238
Study 17912163 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 0
Study 17912163 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary interventions (PCI)
Number of subjects: 0
Study 17912163 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (under investigation)
Number of subjects: 0
Study 12786728 — intervention group
Group type: EXPERIMENTAL
Intervention: Deodorants containing hydroxycitronellal (0.032-0.32%) applied twice daily
Number of subjects: 14
Study 12786728 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without contact allergy to hydroxycitronellal)
Number of subjects: 14
Study 10473959 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinaldehyde 0.05%
Number of subjects: 21
Study 10473959 — intervention group
Group type: COMPARATOR
Intervention: Emollient (control group)
Number of subjects: 21
Study 8659014 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplantation without prior nephrectomy
Number of subjects: 47
Study 8659014 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (with prior nephrectomy)
Number of subjects: 47
Study 1761173 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg oestriol applied daily intravaginally over 3 weeks
Number of subjects: 40
Study 1761173 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg oestriol applied daily intravaginally over 3 weeks
Number of subjects: 40
Study 1761173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7183191 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring group 1
Number of subjects: 50
Study 7183191 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring group 2
Number of subjects: 50
Study 7183191 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring group 3
Number of subjects: 50
Study 7183191 — intervention group
Group type: COMPARATOR
Intervention: No self-monitoring control group 1
Number of subjects: 50
Study 7183191 — intervention group
Group type: COMPARATOR
Intervention: No self-monitoring control group 2
Number of subjects: 50
Study 6234146 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 300
Study 6234146 — intervention group
Group type: EXPERIMENTAL
Intervention: Culdoscopy
Number of subjects: 300
Study 6234146 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparotomy
Number of subjects: 300
Study 29959111 — intervention group
Group type: EXPERIMENTAL
Intervention: My Tools 4 Care (MT4C)
Number of subjects: 199
Study 29959111 — intervention group
Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 199
Study 27005980 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR (self-expandable bioprosthesis)
Number of subjects: 280
Study 27005980 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 280
Study 27005980 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR with severe PPM
Number of subjects: 280
Study 27005980 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVR with severe PPM
Number of subjects: 280
Study 24366034 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 1820
Study 24366034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 1820
Study 24366034 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (weight loss and sodium reduction)
Number of subjects: 1820
Study 24366034 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1820
Study 24366034 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss maintenance
Number of subjects: 1820
Study 24366034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake maintenance
Number of subjects: 1820
Study 24366034 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss and sodium reduction
Number of subjects: 1820
Study 23158073 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP + antihypertensive drugs
Number of subjects: 980
Study 23158073 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive drugs only
Number of subjects: 980
Study 20490904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine therapy (25 mg b.d., for 1 week)
Number of subjects: 14
Study 20490904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine therapy
Number of subjects: 14
Study 20490904 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 14
Study 18300848 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 80-160 mg/day
Number of subjects: 15245
Study 18300848 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5-10 mg/day
Number of subjects: 15245
Study 16113620 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine monotherapy
Number of subjects: 173
Study 16113620 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined atomoxetine/fluoxetine therapy
Number of subjects: 173
Study 16113620 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (with concomitant atomoxetine)
Number of subjects: 173
Study 16113620 — intervention group
Group type: COMPARATOR
Intervention: Placebo (with concomitant atomoxetine)
Number of subjects: 173
Study 12885837 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute infusion of gemcitabine (2,200 mg/m2)
Number of subjects: 92
Study 12885837 — intervention group
Group type: COMPARATOR
Intervention: Fixed dose rate (FDR) infusion of gemcitabine (1,500 mg/m2 over 150 minutes)
Number of subjects: 92
Study 10389788 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 8 mg
Number of subjects: 80
Study 10389788 — intervention group
Group type: COMPARATOR
Intervention: IV saline
Number of subjects: 80
Study 8782169 — intervention group
Group type: COMPARATOR
Intervention: Plasma exchange (PE)
Number of subjects: 45
Study 8782169 — intervention group
Group type: COMPARATOR
Intervention: Selective adsorption using a tryptophan-linked polyvinyl alcohol gel adsorbent
Number of subjects: 45
Study 8782169 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective adsorption followed by intravenous IgG
Number of subjects: 45
Study 1653660 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 8
Study 1653660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6344265 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 0.05 mg/kg
Number of subjects: 60
Study 6344265 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine
Number of subjects: 60
Study 6344265 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study 30642575 — intervention group
Group type: EXPERIMENTAL
Intervention: BET inhibitor (JQ1)
Number of subjects: 100
Study 30642575 — intervention group
Group type: EXPERIMENTAL
Intervention: Computational biology modeling (CBM) predictions
Number of subjects: 100
Study 29551706 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) for 8 weeks (300 mg/120 mg)
Number of subjects: 2041
Study 29551706 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) for 12 weeks (300 mg/120 mg)
Number of subjects: 2041
Study 26400416 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval walking training in water (WG)
Number of subjects: 31
Study 26400416 — intervention group
Group type: COMPARATOR
Intervention: Interval walking training on land (LG)
Number of subjects: 31
Study 25296339 — intervention group
Group type: EXPERIMENTAL
Intervention: Snus users
Number of subjects: 80
Study 25296339 — intervention group
Group type: COMPARATOR
Intervention: Non-snus users
Number of subjects: 80
Study 22828556 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's Lactate 20ml/kg (Group-RL)
Number of subjects: 90
Study 22828556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch-6% 8ml/kg (Group-H)
Number of subjects: 90
Study 22828556 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Ringer's Lactate 10ml/kg and Hydroxyethylstarch-6% 4ml/kg (Group-RLH)
Number of subjects: 90
Study 22828556 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group-RL)
Number of subjects: 90
Study 20430429 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy screening
Number of subjects: 170432
Study 20430429 — intervention group
Group type: COMPARATOR
Intervention: Control group (not contacted)
Number of subjects: 170432
Study 17490966 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace element supplementation (copper, selenium, zinc) administered intravenously for 14-21 days.
Number of subjects: 21
Study 17490966 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace element supplementation (TE group)
Number of subjects: 21
Study 17490966 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control group)
Number of subjects: 21
Study 17490966 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace element supplementation
Number of subjects: 21
Study 16224034 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard technique
Number of subjects: 75
Study 16224034 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard technique facilitated with gastric insufflation
Number of subjects: 75
Study 16224034 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard technique facilitated with the use of preinsertion erythromycin
Number of subjects: 75
Study 16224034 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 75
Study 15561864 — intervention group
Group type: EXPERIMENTAL
Intervention: BB-83698 (10 to 475 mg single dose)
Number of subjects: 0
Study 15561864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10780242 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (20 mg)
Number of subjects: 16
Study 10780242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8526579 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich drink (400 mL, 285 mOsm/kg, 12.0% carbohydrates)
Number of subjects: 12
Study 8526579 — intervention group
Group type: COMPARATOR
Intervention: Water (400 mL)
Number of subjects: 12
Study 6908961 — intervention group
Group type: EXPERIMENTAL
Intervention: Unlocked car door condition
Number of subjects: 116
Study 6908961 — intervention group
Group type: COMPARATOR
Intervention: Locked car door condition
Number of subjects: 116
Study 31270740 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive intradialytic resistance exercise (high or moderate intensity for 12 weeks, 3 times per week)
Number of subjects: 41
Study 31270740 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive intradialytic resistance exercise
Number of subjects: 41
Study 31270740 — intervention group
Group type: COMPARATOR
Intervention: Routine hemodialysis care
Number of subjects: 41
Study 28806217 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg intravenous ondansetron
Number of subjects: 86
Study 28806217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 25403582 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg every 6 months for 3 years) plus tamoxifen (20 mg/day)
Number of subjects: 1803
Study 25403582 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg every 6 months for 3 years) plus anastrozole (1 mg/day)
Number of subjects: 1803
Study 25403582 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 1803
Study 25403582 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole alone
Number of subjects: 1803
Study 23811948 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic training (n = 15)
Number of subjects: 30
Study 23811948 — intervention group
Group type: EXPERIMENTAL
Intervention: Land training (n = 15)
Number of subjects: 30
Study 23811948 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Aquatic and Land)
Number of subjects: 30
Study 21314924 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty (BT)
Number of subjects: 52
Study 21314924 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 19420314 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP), 8 sessions over 4 months
Number of subjects: 0
Study 16704287 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma education program for rural school nurses
Number of subjects: 7
Study 15191584 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic scraper
Number of subjects: 16
Study 15191584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylon multi‐tufted toothbrush
Number of subjects: 16
Study 15191584 — intervention group
Group type: COMPARATOR
Intervention: Control (no tongue cleaning)
Number of subjects: 16
Study 11132749 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 0.017 mg x kg(‐1) administered as a bolus
Number of subjects: 20
Study 9323693 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% soybean fat emulsion with 10% marine fish oil emulsion
Number of subjects: 19
Study 9323693 — intervention group
Group type: COMPARATOR
Intervention: 20% soybean fat emulsion
Number of subjects: 19
Study 8406060 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (2-4 mg in gum base)
Number of subjects: 37
Study 8406060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37